STERIS Announces Details for Q2 Fiscal 2026 Results Call

Conference Call Announcement for STERIS
STERIS plc (NYSE: STE) has announced a significant event for investors and analysts alike. The company is scheduled to host a conference call to discuss its financial performance for the second quarter of fiscal 2026 on November 6, 2025, at 9:00 a.m. ET. This is an opportunity for stakeholders to gain insights directly from the company regarding their latest results.
Accessing the Conference Call
To participate in the conference call, interested parties can tune in live either by phone or through the STERIS investor relations website. For those calling in, the numbers are 1-800-715-9871 within the United States and 1-646-307-1963 for international participants. It's essential for callers to request the STERIS conference call specifically to ensure they are connected.
Replay Information
For those who cannot attend the call live, a replay will be made available at 12:00 p.m. ET on the same day. The replay can be accessed via the same website or by phone using the access code 2170300. The replay phone numbers are 1-877-344-7529 in the U.S. and 1-412-317-0088 internationally.
About STERIS
STERIS is a leading global provider focused on healthcare solutions. The company is dedicated to enhancing patient care through innovative products and services, primarily centered around infection prevention. Their motto reflects a commitment to aiding customers in creating a healthier and safer world. This narrative emphasizes their role in supporting healthcare professionals and facilities worldwide.
Company Contact Information
Individuals looking for more information can reach out to Julie Winter, Vice President of Investor Relations and Corporate Communications at STERIS. Julie can be contacted via email at Julie_Winter@steris.com or by phone at 440.392.7245. STERIS values open communication with its stakeholders and encourages inquiries regarding their operations.
Frequently Asked Questions
What is the date and time of the STERIS conference call?
The conference call is scheduled for November 6, 2025, at 9:00 a.m. ET.
How can I access the live conference call?
You can join the conference call by dialing 1-800-715-9871 in the U.S. or 1-646-307-1963 internationally or by visiting the STERIS investor relations website.
Will a replay of the conference call be available?
Yes, a replay of the conference call will be accessible beginning at 12:00 p.m. ET on November 6, 2025.
Who can I contact for more information about STERIS?
You can contact Julie Winter, Vice President of Investor Relations, at Julie_Winter@steris.com or call 440.392.7245.
What products and services does STERIS provide?
STERIS specializes in various healthcare products and services focused on infection prevention and enhancing patient care in hospitals and healthcare facilities worldwide.
About The Author
Contact Owen Jenkins privately here. Or send an email with ATTN: Owen Jenkins as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.